Disclosure Of First-Time Adoption [Text Block]

Sopharma Trading AD - Filing #6022483

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
123 106 BGN
9 658 BGN
163,000 BGN
70 329 BGN
34 276 BGN
876,000 BGN
27 120 BGN
25 436 BGN
94 545 BGN
225,000 BGN
55 181 BGN
21 441 BGN
34 276 BGN
868,000 BGN
25 773 BGN
225,000 BGN
24 912 BGN
50 463 BGN
84 900 BGN
797,000 BGN
34 276 BGN
Comprehensive income
- BGN
28 561 BGN
- BGN
28 553 BGN
- BGN
8,000 BGN
- BGN
- BGN
- BGN
9 645 BGN
9 574 BGN
- BGN
- BGN
71,000 BGN
Profit (loss)
- BGN
29 208 BGN
- BGN
29 208 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
9 080 BGN
9 080 BGN
- BGN
- BGN
- BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.